Symbol="ACRX"
AssetType="Common Stock"
Name="AcelRx Pharmaceuticals Inc"
Description="AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company is headquartered in Redwood City, California."
CIK="1427925"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="351 GALVESTON DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="13218400"
EBITDA="-30424000"
PERatio="0.19"
PEGRatio="0"
BookValue="1.304"
DividendPerShare="0"
DividendYield="0"
EPS="6.36"
RevenuePerShareTTM="0.214"
ProfitMargin="24.2"
OperatingMarginTTM="-18.11"
ReturnOnAssetsTTM="-0.408"
ReturnOnEquityTTM="0"
RevenueTTM="1771000"
GrossProfitTTM="-5030000"
DilutedEPSTTM="6.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="125"
AnalystTargetPrice="4"
TrailingPE="0.19"
ForwardPE="1.06"
PriceToSalesRatioTTM="11.8"
PriceToBookRatio="0.69"
EVToRevenue="10.28"
EVToEBITDA="0.309"
Beta="0.261"
num_52WeekHigh="7.6"
num_52WeekLow="0.55"
num_50DayMovingAverage="1.015"
num_200DayMovingAverage="1.785"
SharesOutstanding="10924300"
DividendDate="None"
ExDividendDate="None"
symbol="ACRX"
open="1.29"
high="1.29"
low="1.20"
price="1.21"
volume="56275.00"
latest_trading_day="2023-07-14"
previous_close="1.28"
change="-0.07"
change_percent="-5.4688%"
aroon_positive_momentum_days="29"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="29"
Volume_recent_avg="182544"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="29"
Aroon_momentum_negative="71"
image_negative_thumbnail_id_1="494"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_negative_thumbnail_id_2="95"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="648"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0060.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
